Kronos Bio Inc (NASDAQ:KRON)’s traded shares stood at 4.69 million during the latest session, with the company’s beta value hitting 1.76. At the last check today, the stock’s price was $0.69, to imply a decrease of -23.07% or -$0.2 in intraday trading. The KRON share’s 52-week high remains $1.60, putting it -131.88% down since that peak but still an impressive 0.0% since price per share fell to its 52-week low of $0.69. The company has a valuation of $41.87M, with an average of 87150.0 shares in intraday trading volume over the past 10 days and average of 151.82K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Kronos Bio Inc (KRON), translating to a mean rating of 3.00. Of 4 analyst(s) looking at the stock, 0 analyst(s) give KRON a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 4 recommend it as a Buy.
Kronos Bio Inc (NASDAQ:KRON) trade information
After registering a -23.07% downside in the latest session, Kronos Bio Inc (KRON) has traded red over the past five days. The 5-day price performance for the stock is -20.23%, and -15.00% over 30 days. With these gigs, the year-to-date price performance is -27.71%. Short interest in Kronos Bio Inc (NASDAQ:KRON) saw shorts transact 0.67 million shares and set a 4.75 days time to cover.
The extremes give us $1 and $1 for target low and target high price respectively. As such, KRON has been trading -44.93% off suggested target high and -44.93% from its likely low.
KRON Dividends
Kronos Bio Inc has its next earnings report out on 2024-Nov-12. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Kronos Bio Inc (NASDAQ:KRON)’s Major holders
Kronos Bio Inc insiders hold 26.60% of total outstanding shares, with institutional holders owning 32.12% of the shares at 43.76% float percentage. In total, 32.12% institutions holds shares in the company, led by VIDA VENTURES ADVISORS, LLC. As of 2024-06-30, the company held over 2.77 million shares (or 4.6012% of shares), all amounting to roughly $3.43 million.
The next major institution holding the largest number of shares is VANGUARD GROUP INC with 1.92 million shares, or about 3.1994% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $2.38 million.
We also have VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Kronos Bio Inc (KRON) shares. Going by data provided on Dec 31, 2024 , VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds roughly 1.32 shares. This is just over 2.16% of the total shares, with a market valuation of $0.9 million. Data from the same date shows that the other fund manager holds a little less at 559.54, or 0.92% of the shares, all valued at about 0.38 million.
